TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $4.5B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 383.66B 20.17B Feb/2026
Alaunos Therapeutics USD 5M 2M Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Ardelyx USD 1.33B 390M Sep/2025
Arrowhead Research USD 8.47B 3.7B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Corcept Therapeutics USD 8.76B 977M Sep/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 5.74B 21M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025